Therapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America
Journal
Multiple Sclerosis and Related Disorders
ISSN
2211-0348
Date Issued
2023
Author(s)
Juan Ignacio Rojas
Pablo A. López
Juan Criniti
Juan Pablo Pettinicchi
Alejandro Caride
Edgar Patricio Correa Díaz
Ana María Toral Granda
María Angélica Ortiz Yepez
Wilson Alfredo Gualotuña Pachacama
Jefferson Santiago Piedra Andrade
Vanessa Daccach Marques
Elisa Bribiesca Contreras
Enrique Gómez Figueroa
José Flores Rivera
Lorna Galleguillos
Carlos Navas
Herval R. Soares Neto
Fernando Gracia
Edgardo Cristiano
Liliana Patrucco
Jefferson Becker
Fernando Hamuy
Ricardo Alonso
Federico Man
Verónica Tkachuk
Débora Nadur
Marco Lana-Peixoto
Ibis Soto de Castillo
Edgar Carnero Contentti
Type
Resource Types::text::journal::journal article
Subjects
latin america
;
mogad
;
nmosd
;
rituximab
;
strategies
;
therapeutic
;
aquaporin 4
;
autoantibodies
;
humans
;
latin america
;
neuromyelitis optica
;
recurrence
;
retrospective studies
;
rituximab
;
aquaporin 4 antibody
;
myelin oligodendrocyte glycoprotein antibody
;
protein antibody
;
rituximab
;
unclassified drug
;
aquaporin 4
;
autoantibody
;
rituximab
;
adult
;
article
;
cohort analysis
;
controlled study
;
demography
;
disease activity
;
disease association
;
enzyme linked immunosorbent assay
;
expanded disability status scale
;
female
;
follow up
;
human
;
humoral immune deficiency
;
immunofluorescence
;
major clinical study
;
male
;
multicenter study
;
myelin oligodendrocyte glycoprotein antibody associated disease
;
myelin oligodendrocyte glycoprotein antibody associated disease
;
myelooptic neuropathy
;
relapse
;
retrospective study
;
south and central america
;
clinical trial
;
recurrent disease